Inventor · disambiguated record
Li Fu
Also filed as: FU LI · Fu li-wen
15 granted patents·7 pending applications·5 citations·filing 2007–2025
85Inventor score
Files withFU LI10RENSSELAER POLYTECH INST4DALIAN FUSHENG NATURAL MEDICINE DEV CO LTD3NEXEOS DIAGNOSTICS INC2CHINA PETROLEUM & CHEM CORP1
Top patents by PatentIndex Score
22 records- 0174US9333215B2Aqueous solution of 20(R)-ginsenoside RG3 pharmaceutical composition and process thereofFU LI·Filed 2013·Granted May 10, 2016·2 cites·6 claims
- 0270US9670224B2Forsythiaside sulfate and derivatives thereof, preparation method and application thereofFU LI·Filed 2014·Granted Jun 6, 2017·2 cites·10 claims
- 0367US11369629B2Enzymatic preparation of increased anticoagulant bovine sourced heparinRENSSELAER POLYTECH INST·Filed 2020·Granted Jun 28, 2022·0 cites·17 claims
- 0466US10286002B2Application of a phillyrin/phillygeninin composition in preparing a medicine or health care product for alleviating or/and treating viral diseases, and medicine or health care product for treating viral diseasesFU LI·Filed 2014·Granted May 14, 2019·1 cites·6 claims
- 0565US2025382499A1Waterborne coating formulation with polyhedral oligomeric silsesquioxane, synthetic method and application thereofNANO & ADVANCED MATERIALS INST LTD·Filed 2025·Application pending·0 cites
- 0665US2023151400A1Biosynthetic heparinRENSSELAER POLYTECH INST·Filed 2023·Application pending·0 cites
- 0764US10881679B2Application of a phillyrin/phillygeninin composition in preparing a medicine or health care product for alleviating or/and treating viral diseases, and medicine or health care product for treating viral diseasesFU LI·Filed 2019·Granted Jan 5, 2021·0 cites·5 claims
- 0862US10238676B2Application of ginsenoside RG3 in preparing medicine for preventing and/or treating dementia, and medicine for treating dementiaFU LI·Filed 2014·Granted Mar 26, 2019·0 cites·3 claims
- 0962US2024366644A1Anti-inflammatory application of ginsenoside rdFU LI·Filed 2024·Application pending·0 cites
- 1061US11712447B2Methods of manufacturing a high molecular weight heparin compoundNEXEOS DIAGNOSTICS INC·Filed 2022·Granted Aug 1, 2023·0 cites·32 claims
- 1161US10864227B2Enzymatic preparation of increased anticoagulant bovine sourced heparinRENSSELAER POLYTECH INST·Filed 2018·Granted Dec 15, 2020·0 cites·7 claims
- 1260US2023321137A1Methods of manufacturing a high molecular weight heparin compoundNEXEOS DIAGNOSTICS INC·Filed 2023·Application pending·0 cites
- 1356US11414447B2Platinum complex, nitrogen-containing bidentate chelate, and apparatus for providing visible emission or near-infrared emissionUNIV NAT TSING HUA·Filed 2021·Granted Aug 16, 2022·0 cites·7 claims
- 1455US11591628B2Biosynthetic heparinRENSSELAER POLYTECH INST·Filed 2017·Granted Feb 28, 2023·0 cites·18 claims
- 1554US8487090B2Water solution of 20(R)-ginsenoside Rg3 pharmaceutical composition and process thereofFU LI·Filed 2007·Granted Jul 16, 2013·0 cites·4 claims
- 1650US9969766B220(R)-ginsenoside Rg3 polyacylated derivatives, preparation and application thereofFU LI·Filed 2014·Granted May 15, 2018·0 cites·12 claims
- 1749US10675317B2Use of ginseng extract, ginsenoside and ginsenoside derivative in the preparation of medicine or health care product for treating cytomegalovirus infection disordersFU LI·Filed 2016·Granted Jun 9, 2020·0 cites·4 claims
- 1849US2023321125A1Compositions of ginsenoside rg3 and ginsenoside rg5 and their pharmaceutical uses including anti-tumor effectsDALIAN FUSHENG NATURAL MEDICINE DEV CO LTD·Filed 2021·Application pending·0 cites
- 1948US2023338454A1Forsythia suspensa component and optional panax ginseng component and the applicationDALIAN FUSHENG NATURAL MEDICINE DEV CO LTD·Filed 2021·Application pending·0 cites
- 2047US10851280B2Modified asphalt particles and preparation method and use thereofCHINA PETROLEUM & CHEM CORP·Filed 2016·Granted Dec 1, 2020·0 cites·21 claims
- 2144US2023101803A13clpro-targeting phillyrin, derivative thereof, and use thereof against novel coronavirusDALIAN FUSHENG NATURAL MEDICINE DEV CO LTD·Filed 2021·Application pending·0 cites
- 2237US10407455B2Phillygenin glucuronic acid derivative as well as preparation method and application thereofFU LI·Filed 2016·Granted Sep 10, 2019·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Li Fu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →